Ki te kahore he whakakitenga ka ngaro te iwi. Without foresight or vision the people will be lost.
Our purpose
We uphold the articles of Te Tiriti, advancing Māori health and aspirations:
Tino Rangatiratanga
partnership
active protection
options
equity.
To deliver the best health outcomes from New Zealand’s investment in medicines and medical devices.
Our strategic direction
On 1 July 2020, Pharmac began working on its new strategic direction. We want to make an even bigger contribution to our health system and to the health of all New Zealanders.
Our Strategy links together
our purpose as an organisation
the longer-term impacts we want to achieve
what we'll do in the medium term to deliver this.
Our strategic direction is our reference point in a changing environment. It will help us build and strengthen our organisation.
Our strategy supports us to grow fully into our name, Te Pātaka Whaioranga (the ‘storehouse of wellbeing’). As Pharmac, we manage and safeguard something that is valuable to all New Zealanders – the pursuit of wellbeing.
Six strategic priorities
We have identified six strategic priorities which represent the work Pharmac needs to undertake over the next 4 years to drive us towards our desired future. These are:
enhance key functions
medical devices
equitable access and use
data and analytics
public understanding, trust and confidence
relationships and partnerships.
PHARMAC's Strategic Direction at a glance
Our strategic direction
Health system outcomes
People are living longer in good health
People have improved quality of life
Health equity for Māori and all other people.
Our purpose
We uphold the articles of Te Tiriti advancing Māori health and aspirations:
Tino Rangatiratanga
partnership
active protection
options and equity.
To deliver the best health outcomes from New Zealand's investment in medicines and medical devices.
Our impact
Our investment choices enhance wellbeing
Medicines and medicacal devices are used appropriately, equitably, and well.
We play a key role in an effective and equitable health system.
Our strategic priorities 2020–2024
Enhance key functions
We continuously improve the way we work to deliver maximum value to New Zealanders.
Medical devices
We drive better value and more consistent access to hospital medical devices.
Equitable access and use
We enable equitable access and use of medicines and related products through influencing availability affordability, accessibility, acceptability, and appropriateness.
Data and analytics
We measure health outcomes and make evidence-informed decisions, using and making available data and insights from a wide range of sources.
Public understanding, trust, and confidence
We listen to the views of New Zealanders and we communicate clearly and simply.
Relationships and partnerships
We create strong and enduring partnerships across the health system and beyond.
Organisational excellence
Our people are engaged, supported, and have the capabilities to their work.
Our people are enabled with the right ICT tools and capability.
We are future focused and we systematically use performance information to adjust plans and deliver better results.
What we do
Make choices and manage expenditure and supply.
Support and inform good decisions about access and use.
